Phase 4 Hepatitis C Clinical Trials
9 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–9 of 9 trials
Recruiting
Phase 4
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Hepatitis C, ChronicPregnancy; Infection
Catherine Anne Chappell100 enrolled9 locationsNCT05140941
Recruiting
Phase 4
Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)
Hepatitis C
Oswaldo Cruz Foundation30,000 enrolled2 locationsNCT06306300
Not Yet Recruiting
Phase 4
An efficacy study of combined oral doses of glecaprevir/pibrentasvir and sofosbuvir for 16 weeks in hepatitis C patients with documented NS5A resistance who did not respond to previous treatment
Hepatitis C
Auckland District Health Board75 enrolled1 locationACTRN12620000794909
Not Yet Recruiting
Phase 4
Prisons evaluation of a one-stop-shop InterVentiOn to scale-up hepatitis C testing and Treatment: the PIVOT study
Hepatitis C
University of New South Wales720 enrolled1 locationACTRN12619001489189
Terminated
Phase 4
A study of therapy for hepatitis C in pregnancy
PregnancyHepatitis C
Monash Health10 enrolled2 locationsACTRN12619000054112
Completed
Phase 3Phase 4
Fixed twelve weeks duration versus response tailored course of dual Sofosbuvir/Daclatasvir therapy in Egyptian adult and adolescent patients with chronic hepatitis C infection (HCV).
chronic virus hepatitis C infection
Green CRC130 enrolled1 locationACTRN12617000263392
Completed
Phase 4
Treatment of recently acquired hepatitis C infection study
Hepatitis C
The University of New South Wales (acting through the Kirby Institute, formerly the National Centre in HIV Epideiology and Clinical Research))120 enrolled7 locationsACTRN12611000513910
Recruiting
Phase 4
A single-arm, open-label, pilot study evaluating the efficacy and safety of directly observed peginterferon alfa-2a with ribavirin in conjunction with a peer counsellor in patients actively using injecting drugs who have chronic hepatitis C and attend a drug and alcohol centre.
Chronic hepatitis C virus (HCV) infection.Side effects related to chronic Hepatitis C virus (HCV) infection and treatment in active injecting drug users (IDUs).Factors affecting compliance of active injecting drug users (IDUs) for standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection.+1 more
Dr Joe Sasadeusz50 enrolled1 locationACTRN12608000400369
Completed
Phase 4
The Chariot Study
Chronic Hepatitis C genotype 1
Roche Products Pty Ltd816 enrolled1 locationACTRN12605000488606